XTENT to Present at Merriman Curhan Ford & Co.'s Investor Summit 2007

Thursday, September 13, 2007 General News
Email Print This Page Comment bookmark
Font : A-A+

MENLO PARK, Calif., Sept. 12 XTENT, Inc.(Nasdaq: XTNT) today announced that Timothy D. Kahlenberg, Chief FinancialOfficer, will present at the 4th annual Merriman Curhan Ford & Co. InvestorSummit on Monday, September 17, 2007 at 10:45 a.m. Pacific. This event willbe held at the Mark Hopkins InterContinental Hotel in San Francisco. Therewill also be a webcast available at http://www.wsw.com/webcast/mcm7/xtnt/.

About XTENT

XTENT, Inc. is a medical device company focused on developing andcommercializing innovative customizable drug eluting stent (DES) systems forthe treatment of coronary artery disease (CAD). CAD is the most common form ofcardiovascular disease and the number one cause of death in the United Statesand Europe. XTENT(R) Custom NX(R) DES Systems are designed to enable thetreatment of single lesions, long lesions and multiple lesions of varyinglengths and diameters, in one or more arteries with a single device. Note:XTENT(R) Custom NX(R) DES Systems have not been approved for sale by anyregulatory authority.

SOURCE XTENT, Inc.


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store